The DOI matches its Crossref record, with a small difference in title or year; 22 of the 22 references it cites were found in a registry or an index.
Comparative Evaluation of the VITEK 2, Disk Diffusion, Etest, Broth Microdilution, and Agar Dilution Susceptibility Testing Methods for Colistin in Clinical Isolates, Including Heteroresistant Enterobacter cloacae and Acinetobacter baumannii Strains
Open accessAbstract
Increasing antibiotic resistance in gram-negative bacteria has recently renewed interest in colistin as a therapeutic option. The increasing use of colistin necessitates the availability of rapid and reliable methods for colistin susceptibility testing. We compared seven methods of colistin susceptibility testing (disk diffusion, agar dilution on Mueller-Hinton [MH] and Isosensitest agar, Etest on MH and Isosensitest agar, broth microdilution, and VITEK 2) on 102 clinical isolates collected from patient materials during a selective digestive decontamination or selective oral decontamination trial in an intensive-care unit. Disk diffusion is an unreliable method to measure susceptibility to colistin. High error rates and low levels of reproducibility were observed in the disk diffusion test. The colistin Etest, agar dilution, and the VITEK 2 showed a high level of agreement with the broth microdilution reference method. Heteroresistance for colistin was observed in six Enterobacter cloacae isolates and in one Acinetobacter baumannii isolate. This is the first report of heteroresistance to colistin in E. cloacae isolates. Resistance to colistin in these isolates seemed to be induced upon exposure to colistin rather than being caused by stable mutations. Heteroresistant isolates could be detected in the broth microdilution, agar dilution, Etest, or disk diffusion test. The VITEK 2 displayed low sensitivity in the detection of heteroresistant subpopulations of E. cloacae . The VITEK 2 colistin susceptibility test can therefore be considered to be a reliable tool to determine susceptibility to colistin in isolates of genera that are known not to exhibit resistant subpopulations. In isolates of genera known to (occasionally) exhibit heteroresistance, an alternative susceptibility testing method capable of detecting heteroresistance should be used.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“studies have shown a significant correlation between E-test results and MIC values obtained through broth or agar dilution methods [69, 70].”
From Methods for screening and evaluation of antimicrobial activity: A review of protocols, advantages, and limitations (2024) · cites this paper as [69]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,745
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K. P., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,389
Polymyxin and Related Peptide Antibiotics
Storm, D. R., Rosenthal, K. S., & Swanson, P. E. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.003451 · Cited by 759
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Li, J., Nation, R. L., Milne, R. W., Turnidge, J. D., & Coulthard, K. P. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.10.001 · Cited by 573
Polymyxin B Sulfate and Colistin: Old Antibiotics for Emerging Multiresistant Gram-Negative Bacteria
Evans, M. E., Feola, D. J., & Rapp, R. P. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18426 · Cited by 550
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
Li, J., Rayner, C. R., Nation, R. L., Owen, R. J., Spelman, D., Tan, K. E., & Liolios, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00103-06 · Cited by 549
Gales, A. C., Reis, A. O., & Jones, R. N. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.183-190.2001 · Cited by 381
Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests
MacGowan, A. P., & Wise, R. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.17 · Cited by 187
Arroyo, L. A. R., García-Curiel, A., Pachón-Ibáñez, M. E., Llanos, A. C., Ruiz, M. T., Pachón, J., & Aznar, J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.2.903-905.2005 · Cited by 130
Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin
Tan, T. Y., & Ng, S. Y. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01708.x · Cited by 126
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 242
Bir, R., Gautam, H., Arif, N., Chakravarti, P., Verma, J., Banerjee, S., Tyagi, S., Mohapatra, S., Sood, S., Dhawan, B., et al. (2022) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361221080650 · Cited by 21
Kennedy, C. A., Fanning, S., Karczmarczyk, M., Byrne, B., Monaghan, Á., Bolton, D., & Sweeney, T. (2017) · Microbial Drug Resistance · doi:10.1089/mdr.2016.0082 · Cited by 21
McCusker, M. P., Ferreira, D. A., Cooney, D., Alves, B. M., Fanning, S., Pagès, J., Martins, M., & Davin‐Regli, A. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.10.009 · Cited by 21
Mohammadzamani, Z., Khorshidi, A., Khaledi, A., Shakerimoghaddam, A., Moosavi, G. A., & Piroozmand, A. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103946 · Cited by 21
Genteluci, G. L., de Souza, P. A., Gomes, D. B. C., Sousa, V. S., de Souza, M. J., Abib, J. R. L., de Castro, E. A. R., Rangel, K., & Bôas, M. H. S. V. (2020) · Current Microbiology · doi:10.1007/s00284-020-02064-6 · Cited by 22
Rodríguez, C. H., Traglia, G. M., Bastyas, N., Pandolfo, C., Bruni, G., Nastro, M., Barrios, R., Bavastro, E. M., Rey, M. C. C., Marqués, I. A., et al. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.08.010 · Cited by 20
Rennie, R. P., Turnbull, L., Brosnikoff, C., & Cloke, J. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.05395-11 · Cited by 19
What is the clinical significance of ‘heteroresistance’ in nonfermenting Gram-negative strains?
Tiseo, G., Galfo, V., & Falcone, M. (2023) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000964 · Cited by 18
Coevolution of Resistance Against Antimicrobial Peptides
Baindara, P., Ghosh, A., & Mandal, S. (2020) · Microbial Drug Resistance · doi:10.1089/mdr.2019.0291 · Cited by 18
Somily, A. M. (2010) · Saudi Medical Journal · doi:10.15537/1658-3175.5024 · Cited by 17
Roth, B. M., Laps, A., Yamba, K., Heil, E. L., Johnson, J. K., Stafford, K. A., Hachaambwa, L., Kalumbi, M., Mulenga, L., Patel, D. M., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10070782 · Cited by 16
García‐Meniño, I., Lumbreras-Iglesias, P., Valledor, P., Díaz-Jiménez, D., Lestón, L., Fernández, J., & Mora, A. (2020) · Antibiotics · doi:10.3390/antibiotics9120861 · Cited by 16
Mashaly, G. E.-S., & Mashaly, M. E.-S. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2020.11.019 · Cited by 16
Rahimi, M., Piroozmand, A., Shayestehpour, M., Salamat, S., Falak, F. P., Shakerimoghaddam, A., Moosavi, G. A., & Khaledi, A. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08559-2 · Cited by 16
Choi, I. S., Lee, Y. J., Wi, Y. M., Kwan, B. S., Jung, K. H., Hong, W. P., & Kim, J. M. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.05.011 · Cited by 15
Sudhakar, C. (2012) · InTech eBooks · doi:10.5772/2251 · Cited by 16
Heteroresistance to Colistin in Clinical Isolates of Klebsiella pneumoniae Producing OXA-48
Sánchez-León, I., García‐Martínez, T., Diene, S. M., Pérez‐Nadales, E., Martı́nez-Martı́nez, L., & Rolain, J. (2023) · Antibiotics · doi:10.3390/antibiotics12071111 · Cited by 14
İbik, Y. E., Ejder, N., Sevi̇m, E., Rakıcı, E., Tanrıverdi, E. S., & Çiçek, A. Ç. (2023) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-023-00640-9 · Cited by 14
COLISTIN, AN OPTION FOR TREATMENT OF MULTIPLE DRUG RESISTANT PSEUDOMONAS AERUGINOSA
Memar, M. Y., Pormehrali, R., Alizadeh, N., & Ghotaslou, R. (2016) · Cited by 14
Tyrrell, J. M., Aboklaish, A. F., Walsh, T. R., Vaara, T., & Vaara, M. (2018) · Peptides · doi:10.1016/j.peptides.2018.12.006 · Cited by 14
Sarker, S. K., Neeloy, R. M., Habib, M. B., Urmi, U. L., Asad, M. A., Mosaddek, A. S. M., Khan, M. R. K., Nahar, S., Godman, B., & Islam, S. (2024) · Antibiotics · doi:10.3390/antibiotics13060534 · Cited by 14
Das, S., Roy, S., Roy, S., Goelv, G., Sinha, S., Mathur, P., Walia, K., & Bhattacharya, S. (2020) · Indian Journal of Medical Microbiology · doi:10.4103/ijmm.ijmm_19_480 · Cited by 13
Rout, B., Dash, S. K., Sahu, K. K., Behera, B., Praharaj, I., & Otta, S. (2023) · Access Microbiology · doi:10.1099/acmi.0.000595.v3 · Cited by 13
Mathur, P., Khurana, S., de Man, T. J. B., Rastogi, N., Katoch, O., Veeraraghavan, B., Neeravi, A., Venkatesan, M., Kumar, S., Sagar, S., et al. (2019) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2019.252 · Cited by 13
Cielo, N. C., Belmonte, T., Raro, O. H. F., da Silva, R. M. C., Wink, P. L., Barth, A. L., da Cunha, G. R., Mott, M. P., Riche, C. V. W., Dias, C. A. G., et al. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115099 · Cited by 12
Polymyxin Pharmacokinetics and Pharmacodynamics
Cheah, S.-E., Li, J., Bergen, P. J., & Nation, R. L. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3323-5_10 · Cited by 12
Fadana, V., Thomas, T., & von Knorring, N. (2022) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v11i1.1597 · Cited by 11
Evaluation of an In-House Colistin NP Test for Use in Resource-Limited Settings
Mitton, B. C., Kingsburgh, C., Kock, M. M., Mbelle, N. M., & Strydom, K. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.00501-19 · Cited by 11
Wattal, C., Goel, N., Oberoi, J. K., Datta, S., & Raveendran, R. (2019) · Indian Journal of Medical Microbiology · doi:10.4103/ijmm.ijmm_20_92 · Cited by 11
Colistin Resitance in Carbapenem Resistant K. pneumoniae Clinical Isolates
Özkul, C., & Hazırolan, G. (2019) · Türk Mikrobiyoloji Cemiyeti Dergisi · doi:10.5222/tmcd.2019.017 · Cited by 11
Erfani, Y., Rasti, A., Mirsalehian, A., Mirafshar, S. M., & Ownegh, V. (2011) · African Journal of Microbiology Research · doi:10.5897/ajmr10.364 · Cited by 11
Ananda, T., Vandana, K. E., & Mukhopadhyay, C. (2024) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2024.100559 · Cited by 10
Multicenter study of automated systems for colistin susceptibility testing
Anantharajah, A., Glupczynski, Y., Hoebeke, M., Bogaerts, P., Declercq, P., Denis, O., Descy, J., Floré, K., Magerman, K., Rodriguez‐Villalobos, H., et al. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04059-4 · Cited by 10
Mezzatesta, M. L., Caio, C., Gona, F., Zingali, T., Salerno, I., & Stefani, S. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2015.0160 · Cited by 10
Zulfiqar, A., Hanif, F., Irfan, R., Qasim, A., & Usman, J. (2024) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-024-04988-4 · Cited by 9
An update on polymyxin susceptibility testing methods forAcinetobacter baumannii
Dafopoulou, K., Vourli, S., Tsakris, A., & Pournaras, S. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1667230 · Cited by 9
Katsiari, M., Mavroidi, A., Platsouka, E. D., & Nikolaou, C. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.02.006 · Cited by 10
Hu, X., Sun, L.-L., Nie, T., Yan, Y., Wang, X., Pang, J., Lu, X., Li, X., Lu, Y., Li, C., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11101392 · Cited by 9
Mechanisms and Clinical Relevance of Pseudomonas aeruginosa Heteroresistance
Chen, Z. (2023) · Surgical Infections · doi:10.1089/sur.2022.349 · Cited by 10
Acinetobacter baumannii - The Rise of a Resistant Pathogen
Rangel, K., & De-Simone, S. G. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1001504 · Cited by 9
Polymyxin Susceptibility Testing and Breakpoint Setting
Turnidge, J. D., Sei, K., & Mouton, J. W. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-16373-0_9 · Cited by 8
Azzopardi, E. (2013) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 8
Antony, T., Senthilnathan, Y., Madhavakumar, R., Amudhan, P., Venkataraman, S., Rally, S., Pitani, R. S., & Arumugam, I. (2024) · Cureus · doi:10.7759/cureus.65796 · Cited by 7
Koizumi, J., Nakase, K., Noguchi, N., & Nakaminami, H. (2023) · The Journal of Antibiotics · doi:10.1038/s41429-023-00635-w · Cited by 7
Rodríguez, C. H., Maza, J., Tamarin, S., Nastro, M., Vay, C. A., & Famiglietti, A. M. R. (2019) · Journal of Chemotherapy · doi:10.1080/1120009x.2019.1637557 · Cited by 7
Huang, C., Lin, L., & Kuo, S. (2024) · Antibiotics · doi:10.3390/antibiotics13090907 · Cited by 7
Ali, S., Donoghue, O., & McDermott, S. (2025) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002007 · Cited by 6
Bacterial heteroresistance: an evolving novel way to combat antibiotics
Manjunath, A., Thumu, S. C. R., Kumar, S., & Halami, P. M. (2021) · Biologia · doi:10.1007/s11756-021-00820-y · Cited by 6
Ronat, J., Oueslati, S., Natale, A., Kesteman, T., Elamin, W. F., Langendorf, C., Hardy, L., Vandenberg, O., & Naas, T. (2022) · Diagnostics · doi:10.3390/diagnostics12092106 · Cited by 6
Nhung, P. H., Miyoshi‐Akiyama, T., Phuong, D. M., Shimada, K., Anh, N. Q., Bình, N. G., Thành, Đ. V., Ohmagari, N., & Kirikae, T. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.04.002 · Cited by 6
Muerte bacteriana y heterorresistencia a los antimicrobianos
Martı́nez-Martı́nez, L. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)72774-5 · Cited by 6
Muthusamy, D. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/19968.8535 · Cited by 6
Haeili, M., Kafshdouz, M., Pishnian, Z., Feizabadi, M. M., & Martı́nez-Martı́nez, L. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000879 · Cited by 6
Dimitriades, K., Morrow, B. M., & Jeena, P. M. (2013) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-304540 · Cited by 6
Kim, T. Y., Baek, J. Y., Suh, E., Lee, J.-K., Yu, H., Ko, J., Huh, H. J., & Lee, N. Y. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00166-25 · Cited by 5
Chandler, J. C., Franklin, A. B., Bevins, S. N., Bentler, K. T., Bonnedahl, J., Ahlstrom, C. A., Bisha, B., & Shriner, S. A. (2020) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2020.105892 · Cited by 5
Anita, Kumari, R., Saurabh, K., Kumar, S., & Kumari, N. (2023) · Cureus · doi:10.7759/cureus.50894 · Cited by 5
Overview of heteroresistance, persistence and optimized strategies to control them
Marjani, M. F. A., Mohammed, H. N., Al-Kadmy, I. M. S., & Aziz, S. N. (2022) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000325 · Cited by 5
Antibiotic heteroresistance: an important factor in the failure of Helicobacter Pylori eradication
Yu, Y., Xue, J., Zhang, W., Ru, S., Liu, Y., Du, K., & Jiang, F. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2510245 · Cited by 5
Li, H., Zhou, H., Li, X., Wang, J., Fu, Y., Jiang, Y., & Yu, Y. (2017) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.55956 · Cited by 5
Karakonstantis, S., Kritsotakis, E. I., & Gikas, A. I. (2020) · Journal of Chemotherapy · doi:10.1080/1120009x.2020.1839689 · Cited by 5
Evaluation of Diagnostics Colistin MIC-Strip Test for Colistin Susceptibility Testing
Gelmez, G. A., Sayın, E., Hasdemir, U. O., & Söyletir, G. (2021) · ANKEM Dergisi · doi:10.5222/ankem.2021.009 · Cited by 5
Chantziaras, I., Dewulf, J., Boyen, F., Callens, B., & Butaye, P. (2014) · Vlaams Diergeneeskundig Tijdschrift · doi:10.21825/vdt.v83i5.16634 · Cited by 5
Herrera, M., Mobilia, L., & Posse, G. (2011) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 5
Festa, R. A., Cockerill, F. R., Pesano, R. L., Haley, E., Luke, N., Mathur, M., Chen, X., Havrilla, J. M., Percaccio, M., Magallón, J., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14020143 · Cited by 4
Radhakrishnan, R., Rajesh, J. S., Dinesh, N. S., Thangavelu, C. P., & Sankaran, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-60717-9 · Cited by 4
Determination of Colistin Resistance in Gram Negative Bacteria by Modified Broth Disk Elution Method
Tüzemen, N. Ü., Işık, Ö., Akça, B., & Özakın, C. (2022) · Türk Mikrobiyoloji Cemiyeti Dergisi · doi:10.54453/tmcd.2022.37167 · Cited by 4
Kipnis, É., & Guery, B. P. (2010) · Antibiotiques · doi:10.1016/j.antib.2010.10.003 · Cited by 5
Şafak, B., TOMBAK, Ö., & Topkaya, A. E. (2020) · Namık Kemal Tıp Dergisi · doi:10.37696/nkmj.581622 · Cited by 3
Yiş, R. (2022) · Journal of Academic Research in Medicine · doi:10.4274/jarem.galenos.2022.70299 · Cited by 3
Comparison of Colistin Susceptibility Tests
Çiftçi, N., Arslan, U., & Dağı, H. T. (2023) · Sağlık Akademisi Kastamonu · doi:10.25279/sak.1274681 · Cited by 3
Bhatia, M., Shamanna, V., Nagaraj, G., Gupta, P., Omar, B. J., Diksha, Rohilla, R., & Ravikumar, K. L. (2023) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2023.116155 · Cited by 3
Amer, W. H. (2015) · Cited by 3
Polymyxins Resistance in Enterobacteriaceae ☆
Ma, X., He, Y., Cai, R., Zeng, J., Yang, L., Cha, C., & Huang, B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64150-8 · Cited by 3
The Public Health Risks of Colistin Resistance in Dogs and Cats: A One Health Perspective Review
Menezes, J., Fernandes, L., Marques, C., & Pomba, C. (2025) · Antibiotics · doi:10.3390/antibiotics14121213 · Cited by 2
Kumar, M., Bhalla, G. S., Tandel, K., Jain, S., Singh, G., Mahajan, P., Shergill, S. P. S., & Gupta, R. M. (2023) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2023.05.008 · Cited by 2
HETERORESISTANCE: CLINICAL IMPLICATIONS AND DETECTION METHODS (REVIEW OF LITERATURE)
(2023) · Russian Clinical Laboratory Diagnostics · doi:10.51620/0869-2084-2023-68-7-418-427 · Cited by 2
Lo, C. K.-F., Ritchie, G., Bilawka, J., Gowland, L., Chorlton, S. D., Jang, W., Matic, N., Romney, M. G., Stefanovic, A., & Lowe, C. F. (2024) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001881 · Cited by 2
Forstner, P., Fuchs, L., Luxner, J., Grisold, A. J., Steinmetz, I., & Dichtl, K. (2024) · Antibiotics · doi:10.3390/antibiotics13111062 · Cited by 2
Yadav, K., Pawar, S. K., Yadav, S. A., & Patil, S. R. (2024) · Cureus · doi:10.7759/cureus.76646 · Cited by 2
Okasha, H. A. S., & Meheissen, M. A. (2017) · Advances in Microbiology · doi:10.4236/aim.2017.71006 · Cited by 2
Humphry, R. W., Evans, J. A., Webster, C. A., Tongue, S. C., Innocent, G. T., & Gunn, G. J. (2017) · Preventive Veterinary Medicine · doi:10.1016/j.prevetmed.2017.11.012 · Cited by 2
Varshochi, M., Hasani, A., shahverdi, P. P., Ghavghani, F. R., & Matin, S. (2020) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid.91174 · Cited by 5
Singhal, L., Singh, C., & Gautam, V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00199-7 · Cited by 2
Understanding the Harmful Impact of Polymyxins on Acinetobacter baumannii
Rangel, K., Chagas, T. P. G., & De-Simone, S. G. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1003649 · Cited by 1
Kolistin Duyarlılık Testlerinin Güncel Bilgiler Eşliğinde İrdelenmesi
Nadir, Y., & Batırel, A. A. (2024) · Mediterranean Journal of Infection Microbes and Antimicrobials · doi:10.4274/mjima.galenos.2024.24056.3 · Cited by 1
Investigation of Colistin resistance and method comparison in Klebsiella pneumoniae strains
Uysal, A. A., & Tünger, A. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116584 · Cited by 1
Soni, M., Chaurasia, D., Pakhare, A. P., & Kapoor, G. T. (2025) · Cureus · doi:10.7759/cureus.85256 · Cited by 1
Langendorf, C., Ronat, J., Natale, A., Vidal, T., Kodo, H., Oueslati, S., Baillet, B., Franquesa, C., Kouassi, F., Rafaï, C. D., et al. (2025) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2025.108001 · Cited by 3
Ali, S., Wareham, L. K., Poole, R. K., & McLean, S. (2026) · Microbiology · doi:10.1099/mic.0.001669 · Cited by 1
Gashaw, Y., Sisay, A., Getachew, E., Asmare, Z., Geteneh, A., Tamrat, E., Abebe, W., Bitew, G., Birhanu, A., Tigabie, M., et al. (2026) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlag039 · Cited by 1
Liu, Y., Zhou, C., Zhong, G., Zeng, J., Pu, J., Chen, C., He, Y., & Huang, B. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13102-2 · Cited by 1
Kırbaş, E., Işık, M. C., İsmayılov, R., Ünal, S., & Büyükçam, A. (2026) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-026-05576-4 · Cited by 1
Taş, E., & Yücel, F. M. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12234-7 · Cited by 1
Taş, E., & Yücel, F. M. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12280-1 · Cited by 1
Old and Novel Polymyxins Against Serious Gram-Negative Infections
Vaara, M. (2013) · Springer eBooks · doi:10.1007/978-3-642-39968-8_8 · Cited by 1
Coppo, E., Dusi, P. A., Dotta, M., Debbia, E. A., & Marchese, A. E. (2013) · Microbiologia medica · doi:10.4081/mm.2013.3271 · Cited by 1
TANRIVERDİ, Y., Çınar, C., Bılgın, K., Vural, D. G., & Bırıncı, A. (2020) · Sağlık Bilimlerinde Değer · doi:10.33631/duzcesbed.603411 · Cited by 1
Clinical Microbiology in 2021: My Favorite Studies about Everything Except My Least Favorite Virus
Pettengill, M. A. (2022) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2022.04.003 · Cited by 1
Detection and Phenotypic Characterization of Colistin-Resistant Bacteria in Water
Osisiogu, E. U., Appiah, C. A., Mahmoud, F. C., Bawa, F. K., & Nattah, E. M. (2023) · Science International · doi:10.17311/sciintl.2023.09.17 · Cited by 1
Metadata
- Authors
- Lo-Ten-Foe, J. R., de Smet, A. M. G. A., Diederen, B. M. W., Kluytmans, J. A. J. W., & van Keulen, P. H. J.
- Affiliations
- Laboratory for Microbiology and Infection Control, Amphia Hospital, Breda, The Netherlands
- University Medical Center Utrecht (NL)
- Amphia Ziekenhuis (NL)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-10
- Volume
- 51
- Issue
- 10
- Pages
- 3726-3730
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2043258
- OpenAlex
- W2142419984
- Cited by
- 242
- References
- 22
- Citations by year
- 2026: 15 · 2025: 10 · 2024: 16 · 2023: 19 · 2022: 14 · 2021: 9 · 2020: 22 · 2019: 16 · 2018: 19 · 2017: 24 · 2016: 13 · 2015: 11 · 2014: 9 · 2013: 11 · 2012: 7
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- colistin, colistin susceptibility testing, heteroresistance, Enterobacter cloacae, Acinetobacter baumannii, disk diffusion, E-test, broth microdilution, agar dilution, VITEK 2, selective decontamination of the digestive tract, intensive care unit, Gram-negative bacteria, antibiotic resistance
- MeSH terms
- Acinetobacter Infections, Agar, Anti-Bacterial Agents, Bacterial Infections, Colistin, Cross Infection, Culture Media, Enterobacteriaceae Infections, Humans, Intensive Care Units, Microbial Sensitivity Tests, Polymyxin B, Enterobacter cloacae, Drug Resistance, Multiple, Bacterial, Acinetobacter baumannii
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review